Skip to main content

Table 1 Demographics and Indications

From: Propensity score adjusted comparison of three-factor versus four-factor prothrombin complex concentrate for emergent warfarin reversal: a retrospective cohort study

Variables

PCC3 (n = 57)

PCC4 (n = 23)

Characteristics

 Age (years)a

74.0 (62.0–80.0)

66.0 (57.0–82.0)

 Weight (kg)a

81.4 (72.1–94.4)

77.8 (64.7–97.8)

Sex, n (%)

 Male

36 (63.2%)

12 (52.2%)

 Female

21 (36.8%)

11 (47.8%)

Indication for warfarin, n (%)

 Atrial Arrhythmias

32 (56.1%)

8 (34.8%)

 DVT/PEb

7 (12.8%)

4 (17.4%)

 Valve replacement

6 (10.5%)

5 (21.7%)

 Ischemia CVA

4 (7.0%)

1 (4.3%)

 Other

8 (14.0%)

5 (21.7%)

Bleed type, n (%)

 Intracranial

31 (54.4%)

19 (82.6%)

 Gastrointestinal

10 (17.5%)

2 (8.7%)

 Other

16 (28.1%)

2 (8.7%)

  1. CVA cerebrovascular accident, DVT/PE deep vein thrombosis and/or pulmonary embolism, EWR emergent warfarin reversal, PCC3 3-factor prothrombin complex concentrate, PCC4 4-factor prothrombin complex concentrate
  2. aAge and Weight given as median (25th–75th percentiles)
  3. bProphylaxis or treatment